Biomarkers for Short-Term Omalizumab Response in Chronic Spontaneous Urticaria-Reference-Cited by-同舟云学术

Biomarkers for Short-Term Omalizumab Response in Chronic Spontaneous Urticaria

Published:2024 Issue: Volume:36 Page:
ISSN:1013-9087
Container-title:Annals of Dermatology
language:en
Short-container-title:Ann Dermatol

Author:

Kim Wanjin¹²³^ORCID,Kim Su Min¹⁴^ORCID,Oh Jongwook¹⁵^ORCID,Park HeeUng²^ORCID,Lee Jiwon²^ORCID,Ryu Soorack⁶^ORCID,Kim Lark Kyun⁴^ORCID,Cho Han Kyoung²^ORCID,Park Kyung Hee⁷⁸^ORCID,Lee Jae-Hyun⁷⁸^ORCID,Park Jung-Won⁷⁸^ORCID,Park Chang Ook¹⁸^ORCID

Affiliation:

1. Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Dermatology, Myongji Hospital, Goyang, Korea.

3. Yonsei University College of Medicine, Seoul, Korea.

4. Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.

6. Biostatistical Consulting and Research Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea.

7. Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

8. Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.

Funder

Ministry of Health and Welfare

National Research Foundation of Korea

Publisher

XMLink

Link

https://anndermatol.org/pdf/10.5021/ad.24.004

Reference27 articles.

1. Omalizumab chronic spontaneous urticaria

2. Current and emerging treatments for chronic spontaneous urticaria

3. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence

4. New treatments for chronic urticaria

5. Omalizumab in Children